ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 92 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $211,000 | -72.5% | 6,391 | -61.7% | 0.03% | -51.5% |
Q1 2022 | $767,000 | +127.6% | 16,684 | +228.0% | 0.07% | +153.8% |
Q4 2021 | $337,000 | -69.3% | 5,087 | -71.0% | 0.03% | -67.1% |
Q3 2021 | $1,096,000 | +49.5% | 17,554 | +98.3% | 0.08% | +64.6% |
Q2 2021 | $733,000 | +218.7% | 8,854 | +65.7% | 0.05% | +220.0% |
Q3 2020 | $230,000 | -83.8% | 5,344 | -94.9% | 0.02% | -72.2% |
Q2 2018 | $1,421,000 | -57.1% | 104,500 | -77.3% | 0.05% | -51.8% |
Q1 2018 | $3,312,000 | +168.4% | 459,400 | +37.1% | 0.11% | +211.1% |
Q4 2017 | $1,234,000 | – | 335,200 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |